SUN2 p.Leu89Arg
c.266T>G · rs35496634 · VCV1167140
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0712 | likely benign |
|---|---|---|
| REVEL | 0.079 | moderately benign-leaning |
| SaProt | LLR -6.21 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.8 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.94 | unconstrained · MANE · 12 kb · p 0.11 · regional, not allelic |
| Overall | ||
| CADD | 20.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 23.2% | 4 |
| Finnishnot grpmax-eligible | 14.2% | 7 |
| European (non-Finnish)grpmax | 11.1% | 9 |
| Ashkenazi Jewishnot grpmax-eligible | 8.65% | 12 |
| Remaining individualsnot grpmax-eligible | 8.54% | 12 |
| Middle Eastern | 7.21% | 14 |
| Admixed American | 5.01% | 20 |
| African / African-American | 1.76% | 57 |
| South Asian | 1.63% | 61 |
| East Asian | 0.0245% | 4,077 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SUN2
- Protein
- p.Leu89Arg
- Coding
- c.266T>G
- MANE Select
- NM_015374
- dbSNP
- rs35496634
- Type
- single nucleotide variant
- Location
- chr22:38751230 (GRCh38)
- Gene constraint
- LOEUF 0.756 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 68.48 · 9 PDB
- Residue 89
- a UniProt-annotated variant site (in); the 'lmna-binding' region
Disease context
Emery-Dreifuss muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Emery-Dreifuss muscular dystrophy (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, X-linked recessive
- Onset
- Childhood
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- SUN2 p.Leu89Trp Uncertain significance ★ same residue
- SUN2 p.Ala158Thr Uncertain significance ★★ ⚠ same condition
- SUN2 p.Ala251Val Uncertain significance ★★ ⚠ same condition
- SUN2 p.Ala508Val Uncertain significance ★★ ⚠ same condition
- SUN2 p.Ala56Val Uncertain significance ★★ ⚠ same condition
- SUN2 p.Arg100Gln Uncertain significance ★★ ⚠ same condition
- SUN2 p.Arg102Gln Uncertain significance ★★ ⚠ same condition
- SUN2 p.Arg102Trp Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sun2-p-leu89arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown